Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Buy
60,004
+46,195
+335% +$1.04M ﹤0.01% 1922
2025
Q4
$300K Buy
+13,809
New +$283K ﹤0.01% 2382
2024
Q3
Sell
-12,102
Closed -$297K 2967
2024
Q2
$297K Buy
+12,102
New +$292K ﹤0.01% 1506
2021
Q3
Sell
-20,346
Closed -$534K 3647
2021
Q2
$534K Buy
+20,346
New +$541K ﹤0.01% 1710
2021
Q1
Sell
-13,433
Closed -$374K 3047
2020
Q4
$374K Sell
13,433
-24,192
-64% -$673K 0.01% 1167
2020
Q3
$1.02M Buy
37,625
+10,951
+41% +$305K 0.03% 528
2020
Q2
$651K Buy
+26,674
New +$634K 0.02% 685

Other funds holding PHI

HRT Financial's PHI Position: Q1 2026 in Review

HRT Financial increased its PLDT (PHI) stake by 335% in Q1 2026, buying an estimated $1.04M and bringing the position to 60,004 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

HRT Financial first reported a position in PHI in Q2 2020 and has held it in 7 quarters since. 102 funds tracked by Wall St. Rank hold PHI as of Q1 2026.

  • HRT Financial held 60,004 shares of PLDT worth $1.26M as of Q1 2026.
  • HRT Financial bought 46,195 PLDT shares in Q1 2026, an estimated $1.04M.
  • PLDT made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1922 holding.
  • HRT Financial first reported a position in PLDT in Q2 2020 and has held it in 7 quarters since.
  • 102 funds tracked by Wall St. Rank held PLDT as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.